1. Home
  2. AZTR vs XWEL Comparison

AZTR vs XWEL Comparison

Compare AZTR & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.20

Market Cap

2.2M

Sector

Health Care

ML Signal

HOLD

XWEL

XWELL Inc.

HOLD

Current Price

$0.44

Market Cap

2.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTR
XWEL
Founded
2014
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.3M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
AZTR
XWEL
Price
$0.20
$0.44
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
1.8M
1.3M
Earning Date
02-20-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$29,523,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$0.26
52 Week High
$2.97
$1.42

Technical Indicators

Market Signals
Indicator
AZTR
XWEL
Relative Strength Index (RSI) 27.99 56.68
Support Level $0.19 $0.33
Resistance Level $0.22 $0.42
Average True Range (ATR) 0.02 0.07
MACD -0.00 0.03
Stochastic Oscillator 2.99 95.91

Price Performance

Historical Comparison
AZTR
XWEL

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About XWEL XWELL Inc.

XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers with premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.

Share on Social Networks: